Prednisolone Sodium Phosphate

Product NDC: 66993-844
11-digit product format: 669930844
Labeler code: 66993
Product ID: 66993-844_4995189d-7448-4175-b720-8f1b7c1ff39e
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: prednisolone sodium phosphate
Dosage form: TABLET, ORALLY DISINTEGRATING
Route: ORAL
Labeler: Prasco Laboratories
Application: NDA021959
Marketing category: NDA AUTHORIZED GENERIC
Marketing start: 2015-10-21
Marketing end: 0000-00-00
Substance: PREDNISOLONE SODIUM PHOSPHATE
Active strength: 10 mg/1
Pharmacologic classes: Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	66993-844		D	Discontinued by firm	2026-08-03
excluded package	package	66993-844	66993-844-35	D	Discontinued by firm	2026-08-03
excluded package	package	66993-844	66993-844-62	D	Discontinued by firm	2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 14 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	66993-844-35	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	66993-844-62	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	66993-844-62	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	66993-844-62	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	66993-844-62	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	66993-844-62	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	66993-844-62	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	66993-844-62	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	66993-844-62	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	66993-844-62	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	66993-844-62	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	66993-844-62	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	66993-844-62	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N021959-001	ORAPRED ODT	PREDNISOLONE SODIUM PHOSPHATE	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01
N021959-002	ORAPRED ODT	PREDNISOLONE SODIUM PHOSPHATE	EQ 15MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01
N021959-003	ORAPRED ODT	PREDNISOLONE SODIUM PHOSPHATE	EQ 30MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2006-06-01

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021959-001	ORAPRED ODT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021959-002	ORAPRED ODT	EQ 15MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021959-003	ORAPRED ODT	EQ 30MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2006-06-01	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021959-001	ORAPRED ODT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021959-002	ORAPRED ODT	EQ 15MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021959-003	ORAPRED ODT	EQ 30MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2006-06-01	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021959-001	ORAPRED ODT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021959-002	ORAPRED ODT	EQ 15MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021959-003	ORAPRED ODT	EQ 30MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2006-06-01	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021959-001	ORAPRED ODT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021959-002	ORAPRED ODT	EQ 15MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021959-003	ORAPRED ODT	EQ 30MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2006-06-01	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021959-001	ORAPRED ODT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021959-002	ORAPRED ODT	EQ 15MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021959-003	ORAPRED ODT	EQ 30MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2006-06-01	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021959-001	ORAPRED ODT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021959-002	ORAPRED ODT	EQ 15MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021959-003	ORAPRED ODT	EQ 30MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2006-06-01	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021959-001	ORAPRED ODT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021959-002	ORAPRED ODT	EQ 15MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021959-003	ORAPRED ODT	EQ 30MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2006-06-01	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021959-001	ORAPRED ODT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021959-002	ORAPRED ODT	EQ 15MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021959-003	ORAPRED ODT	EQ 30MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2006-06-01	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021959-001	ORAPRED ODT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021959-002	ORAPRED ODT	EQ 15MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021959-003	ORAPRED ODT	EQ 30MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2006-06-01	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021959-001	ORAPRED ODT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021959-002	ORAPRED ODT	EQ 15MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021959-003	ORAPRED ODT	EQ 30MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2006-06-01	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021959-001	ORAPRED ODT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021959-002	ORAPRED ODT	EQ 15MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021959-003	ORAPRED ODT	EQ 30MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2006-06-01	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021959-001	ORAPRED ODT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021959-002	ORAPRED ODT	EQ 15MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021959-003	ORAPRED ODT	EQ 30MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2006-06-01	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021959-001	ORAPRED ODT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021959-002	ORAPRED ODT	EQ 15MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021959-003	ORAPRED ODT	EQ 30MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD, RS	2006-06-01	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021959-001	ORAPRED ODT	EQ 10MG BASE	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2006-06-01	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N021959-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021959-002	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021959-003	AB	1	`74a2ff9319b5…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021959-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021959-002	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021959-003	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021959-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N021959-002	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N021959-003	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021959-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021959-002	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021959-003	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021959-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021959-002	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021959-003	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021959-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021959-002	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021959-003	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021959-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021959-002	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021959-003	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021959-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021959-002	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021959-003	AB	1	`ea99ee380514…`

Observed Orange Book patent history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Coverage / status	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N021959-001	6740341	2019-11-24	Drug product	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021959-002	6740341	2019-11-24	Drug product	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021959-003	6740341	2019-11-24	Drug product	`74a2ff9319b5…`
2019-12-14 00:12 UTC	2019-12	N021959-001	6740341	2019-11-24	Drug product	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021959-002	6740341	2019-11-24	Drug product	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021959-003	6740341	2019-11-24	Drug product	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021959-001	6740341	2019-11-24	Drug product	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021959-002	6740341	2019-11-24	Drug product	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021959-003	6740341	2019-11-24	Drug product	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021959-001	6740341	2019-11-24	Drug product	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021959-002	6740341	2019-11-24	Drug product	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021959-003	6740341	2019-11-24	Drug product	`ea99ee380514…`

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
66993-844-35	EA - Each	66993-844	58384c52-f0b3-4513-a741-83a2c2c90d24	1	2021-01-08
66993-844-51	EA - Each	66993-844	d1c4fdab-f436-4808-b9cd-ddfb09ca6bb8	1	2020-04-20
66993-844-62	EA - Each	66993-844	ce372e55-44c0-4d11-8f8e-0f023b6f7b90	1	2015-12-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
PREDNISOLONE SODIUM PHOSPHATE	ACTIVE INGREDIENT	IV021NXA9J	PREDNISOLONE SODIUM PHOSPHATE ODT (PREDNISOLONE SODIUM PHOSPHATE) TABLET, ORALLY DISINTEGRATING PREDNISOLONE SODIUM PHOSPHATE TABLET, ORALLY DISINTEGRATING [PRASCO LABORATORIES]	1
PREDNISOLONE	ACTIVE MOIETY	9PHQ9Y1OLM	PREDNISOLONE SODIUM PHOSPHATE ODT (PREDNISOLONE SODIUM PHOSPHATE) TABLET, ORALLY DISINTEGRATING PREDNISOLONE SODIUM PHOSPHATE TABLET, ORALLY DISINTEGRATING [PRASCO LABORATORIES]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	PREDNISOLONE SODIUM PHOSPHATE ODT (PREDNISOLONE SODIUM PHOSPHATE) TABLET, ORALLY DISINTEGRATING PREDNISOLONE SODIUM PHOSPHATE TABLET, ORALLY DISINTEGRATING [PRASCO LABORATORIES]	1
CITRIC ACID MONOHYDRATE	INACTIVE INGREDIENT	2968PHW8QP	PREDNISOLONE SODIUM PHOSPHATE ODT (PREDNISOLONE SODIUM PHOSPHATE) TABLET, ORALLY DISINTEGRATING PREDNISOLONE SODIUM PHOSPHATE TABLET, ORALLY DISINTEGRATING [PRASCO LABORATORIES]	1
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	PREDNISOLONE SODIUM PHOSPHATE ODT (PREDNISOLONE SODIUM PHOSPHATE) TABLET, ORALLY DISINTEGRATING PREDNISOLONE SODIUM PHOSPHATE TABLET, ORALLY DISINTEGRATING [PRASCO LABORATORIES]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	PREDNISOLONE SODIUM PHOSPHATE ODT (PREDNISOLONE SODIUM PHOSPHATE) TABLET, ORALLY DISINTEGRATING PREDNISOLONE SODIUM PHOSPHATE TABLET, ORALLY DISINTEGRATING [PRASCO LABORATORIES]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	PREDNISOLONE SODIUM PHOSPHATE ODT (PREDNISOLONE SODIUM PHOSPHATE) TABLET, ORALLY DISINTEGRATING PREDNISOLONE SODIUM PHOSPHATE TABLET, ORALLY DISINTEGRATING [PRASCO LABORATORIES]	1
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	PREDNISOLONE SODIUM PHOSPHATE ODT (PREDNISOLONE SODIUM PHOSPHATE) TABLET, ORALLY DISINTEGRATING PREDNISOLONE SODIUM PHOSPHATE TABLET, ORALLY DISINTEGRATING [PRASCO LABORATORIES]	1
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)	INACTIVE INGREDIENT	74G4R6TH13	PREDNISOLONE SODIUM PHOSPHATE ODT (PREDNISOLONE SODIUM PHOSPHATE) TABLET, ORALLY DISINTEGRATING PREDNISOLONE SODIUM PHOSPHATE TABLET, ORALLY DISINTEGRATING [PRASCO LABORATORIES]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	PREDNISOLONE SODIUM PHOSPHATE ODT (PREDNISOLONE SODIUM PHOSPHATE) TABLET, ORALLY DISINTEGRATING PREDNISOLONE SODIUM PHOSPHATE TABLET, ORALLY DISINTEGRATING [PRASCO LABORATORIES]	1
SODIUM BICARBONATE	INACTIVE INGREDIENT	8MDF5V39QO	PREDNISOLONE SODIUM PHOSPHATE ODT (PREDNISOLONE SODIUM PHOSPHATE) TABLET, ORALLY DISINTEGRATING PREDNISOLONE SODIUM PHOSPHATE TABLET, ORALLY DISINTEGRATING [PRASCO LABORATORIES]	1
SUCRALOSE	INACTIVE INGREDIENT	96K6UQ3ZD4	PREDNISOLONE SODIUM PHOSPHATE ODT (PREDNISOLONE SODIUM PHOSPHATE) TABLET, ORALLY DISINTEGRATING PREDNISOLONE SODIUM PHOSPHATE TABLET, ORALLY DISINTEGRATING [PRASCO LABORATORIES]	1
SUCROSE	INACTIVE INGREDIENT	C151H8M554	PREDNISOLONE SODIUM PHOSPHATE ODT (PREDNISOLONE SODIUM PHOSPHATE) TABLET, ORALLY DISINTEGRATING PREDNISOLONE SODIUM PHOSPHATE TABLET, ORALLY DISINTEGRATING [PRASCO LABORATORIES]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
66993-844	PREDNISOLONE SODIUM PHOSPHATE ODT (PREDNISOLONE SODIUM PHOSPHATE) TABLET, ORALLY DISINTEGRATING PREDNISOLONE SODIUM PHOSPHATE TABLET, ORALLY DISINTEGRATING [PRASCO LABORATORIES]	8	Legacy NDC	20240718_c1853cf5-1f60-4e5b-aeef-9bc907ea8b5f.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Orapred ODT	PREDNISOLONE SODIUM PHOSPHATE	Advanz Pharma (US) Corp.	1e379543-c4cf-4e72-953b-db15b7f0c2a1	2025-06-03	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021959 application number: NDA021959
prednisolone sodium phosphate ODT	PREDNISOLONE SODIUM PHOSPHATE	Ingenus Pharmaceuticals, LLC	ebbc1751-9381-4db1-89ff-ae5a2963fb2c	2024-04-18	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021959 application number: NDA021959

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
IV021NXA9J	PREDNISOLONE SODIUM PHOSPHATE	125-02-0	PREDNISOLONE SODIUM PHOSPHATE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
66993-844-35	66993084435	2 BLISTER PACK in 1 CARTON (66993-844-35) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (66993-844-51)	2 blister pack	2020-10-01	0000-00-00	No	No	Current
66993-844-62	66993084462	8 BLISTER PACK in 1 CARTON (66993-844-62) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (66993-844-51)	8 blister pack	2015-10-21	0000-00-00	No	No	Current